Simplifying Dissolution Testing: Opt-Diss UV Fiber Optic System Software Rev. 3.20 Delivers Streamlined Processes and Expanded Capabilities

Distek, Inc., a well-reputed leader in laboratory pharmaceutical instruments, is excited to announce the release of the latest software update for the Opt-Diss – In-Situ Fiber Optic UV System for Dissolution Testing: Version 3.20.

Study reveals obesity’s link to increased risk of multiple sclerosis and ischemic stroke

The genetic relationship between body mass index (BMI) and multiple neurological diseases.

March 29, 2024

Opinion | We’ve Done Away With a Critical Source of Drug Use Data

Berger is a public health and behavioral health program coordinator. More than 2 years before COVID-19, HHS declared a public health emergency for opioid-related overdoses.

January 9, 2024

Increased daily step count may reduce the risk of death and cardiovascular disease

Every additional step up to around 10,000 steps per day reduces the risk of death and cardiovascular disease (CVD), regardless of how much remaining time

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.